Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Proposed Rule to Implement…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the proposed Outbound Investment Security Program (OISP) rule:"The Administration is correct that…
Learn more
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step…
Learn more
BIO Statement on Finalization of the Globe Model
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model.“Biotechnology is one of America's greatest strengths, delivering…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Statement on the United States-Mexico-Canada Agreement
October 4, 2018
Washington, D.C. (October 4, 2018) – Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):“BIO supports the USMCA and appreciates…
BIO Joins Alliance to Protect Medical Innovation
October 4, 2018
"Innovation and bad public policy cannot coexist. That’s an important message often neglected in the debate about health care costs, and that’s precisely the message this organization will help deliver.”
BIO Applauds House Passage of the American Innovation Act
September 27, 2018
Bill reforms tax rules that currently penalize investment in job creation, innovation Washington, DC (September 27, 2018) – The Biotechnology Innovation Organization (BIO) today applauded the House of Representatives for passing the…
BIO Praises Passage of Small Business Innovation Protection Act
September 26, 2018
Washington, D.C. (September 26, 2018) – The Biotechnology Innovation Organization applauds the House and Senate’s bipartisan passage of the Small Business Innovation Protection Act. The bill directs increased cooperation between the Small Business…
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
September 25, 2018
Legislation will strengthen pipeline of medical countermeasures against serious public health threats Washington, DC (September 25, 2018) – The Biotechnology Innovation Organization (BIO) today applauds the House of Representatives for…
BIO Applauds Release of New National Biodefense Strategy
September 19, 2018
“I applaud the Administration for recognizing the importance of strengthening our national biodefense and preparedness efforts. Our nation continues to face a wide range of biological threats, and this strategy is an important step in the right…
BIO Applauds Senate Passage of Opioid Crisis Response Act of 2018
September 17, 2018
“BIO’s member companies are committed to unleashing the power of scientific innovation to develop solutions that will lead to an America free of prescription opioid addiction. Today’s vote advances vital legislation that will help get new…
BIO Applauds Legislation to Spur Investment in Start-ups
September 12, 2018
Washington, DC (September 12, 2018) – The Biotechnology Innovation Organization (BIO) today applauded the introduction of the American Innovation Act of 2018 (H.R. 6756), which includes a provision that would protect investments in start-ups…
BIO Announces Programming for the 17th Annual BIO Investor Forum
September 4, 2018
Amidst a healthy investment climate for biotech companies, BIO announces programming for the 17th annual BIO Investor Forum
BIO Urges EPA to Help Boost America’s Rural Economy
August 20, 2018
On Friday, August 17, the Biotechnology Innovation Organization (BIO) urged the Environmental Protection Agency (EPA) to use its authority under the Renewable Fuel Standard (RFS) program to strengthen America’s biobased economy.